Patents by Inventor David Alan Boas

David Alan Boas has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10010277
    Abstract: A cancer screening method includes changing a compression state of selected tissue; and obtaining a signal indicative of a response of an optical property of the selected tissue in response to the change in the compression state.
    Type: Grant
    Filed: June 21, 2007
    Date of Patent: July 3, 2018
    Assignee: The General Hospital Corporation
    Inventors: Stefan A. Carp, David Alan Boas
  • Publication number: 20110152249
    Abstract: Evaluating hemodynamic parameters in the cortex can be used as an objective test for CNS activity, e.g., pain.
    Type: Application
    Filed: December 23, 2005
    Publication date: June 23, 2011
    Applicants: THE GENERAL HOSPITAL CORPORATION, THE BRIGHAM AND WOMEN'S HOSPITAL, INC.
    Inventors: David Borsook, Lino Becerra, David Alan Boas, Reuben Mezrich
  • Publication number: 20090164130
    Abstract: Methods, apparatus (100), and computer program products for determining lifetimes and distribution of fluorophores (102) embedded in samples (104). Fluorophores are placed into the sample, light from a source (110) selected to excite the fluorophores illuminates the sample, light emitted from the excited fluorophores is detected by a device (138), and a time-domain analysis is performed on the detected emitted light to determine a three-dimensional distribution of the fluorophores in the sample.
    Type: Application
    Filed: June 9, 2006
    Publication date: June 25, 2009
    Inventors: Anand T. N. Kumar, David Alan Boas, Adrew K. Dunn
  • Patent number: 7047055
    Abstract: A fetal blood pulse oximetry method and apparatus using a first wavelength of light at about 655 to 705 nm and a second wavelength of light at about 820 to 900 nm. Measurements are taken through a mother's abdomen. Processing is performed to extract absorption information related to fetal arterial blood with calculation of fetal oxygen saturation from the extracted data.
    Type: Grant
    Filed: January 26, 2001
    Date of Patent: May 16, 2006
    Assignees: The General Hospital Corporation, The University
    Inventors: David Alan Boas, Anna Zourabian
  • Publication number: 20040116789
    Abstract: A fetal blood pulse oximetry method and apparatus using a first wavelength of light at about 655 to 705 nm and a second wavelength of light at about 820 to 900 nm. Measurements are taken through a mother's abdomen. Processing is performed to extract absorption information related to fetal arterial blood with calculation of fetal oxygen saturation from the extracted data.
    Type: Application
    Filed: February 5, 2004
    Publication date: June 17, 2004
    Inventors: David Alan Boas, Anna Zourabian
  • Patent number: 6577884
    Abstract: The invention relates to a method of using diffuse optical tomography and oxygen in a stroke patient, or a patient suspected of having a stroke, to detect ischemic events or bleeds in the brain.
    Type: Grant
    Filed: June 19, 2000
    Date of Patent: June 10, 2003
    Assignee: The General Hospital Corporation
    Inventor: David Alan Boas
  • Patent number: 6549284
    Abstract: The invention features a calibration method for diffuse optical measurements that corrects transmittance measurements between a source and a detector for factors unrelated to sample properties. The calibration method is based on the same set of transmittance measurements that are subsequently corrected by the calibration and used in imaging and/or spectroscopy applications. The calibration method involves a forward calculation for each of multiple source-detector pairs based on an approximate model of the sample, and a minimization of an expression that depends on the forward calculations and the transmittance measurements to determine self-consistent coupling coefficients for every source-detector pair. Once the coupling coefficients have been determined, they can be used to correct the transmittance measurements. If desired, an inverse calculation can be performed on the corrected sample measurements to determine spatial variations in the optical properties of the sample.
    Type: Grant
    Filed: September 15, 2000
    Date of Patent: April 15, 2003
    Assignee: The General Hospital Corporation
    Inventors: David Alan Boas, Xuefeng Cheng
  • Patent number: 6516214
    Abstract: The invention relates to a method of using diffuse optical tomography and a blood-borne dye in a stroke patient, or a patient suspected of having a stroke, to detect ischemic events or bleeds in the brain.
    Type: Grant
    Filed: January 25, 2000
    Date of Patent: February 4, 2003
    Assignee: The General Hospital Corporation
    Inventor: David Alan Boas
  • Publication number: 20020190212
    Abstract: The invention is based on the discovery that indirect, three-dimensional images of features within turbid or dense samples can be reconstructed based on principles of radiative transport to provide higher resolution images than diffuse imaging methods, while enabling penetration depths significantly greater than microscopic imaging methods. The new indirect mode imaging methods enable one to “see” into turbid or dense samples, such as tissue in living animals or humans, ceramics, plastics, liquids, and other materials, to a depth of 50 &mgr;m to 10 mm or more, with higher resolution than diffuse imaging methods.
    Type: Application
    Filed: December 14, 2001
    Publication date: December 19, 2002
    Inventors: David Alan Boas, Andrew K. Dunn